Selective advantage of HIV protease mutations associated with resistance to lopinavir

被引：0
|
作者：
Molla, A. [1 ]
Lu, L. [1 ]
King, M. [1 ]
Woods, R. [2 ]
Pilot-Matias, T. [1 ]
Lam, E. [3 ]
Whitcomb, J. [3 ]
Bernstein, B. [1 ]
Hanna, G. [1 ]
Kempf, D. [1 ]
机构：
[1] Global Pharmaceut Res & Dev, Abbott Pk, IL USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Monogram Biosci, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [41] Peptide prodrugs: Improved oral absorption of lopinavir, a HIV protease inhibitor
    Agarwal, Sheetal
    Boddu, S. H. S.
    Jain, Ritesh
    Samanta, Swapan
    Pal, Dhananjay
    Mitra, Ashim K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 359 (1-2) : 7 - 14
  • [42] A systematic analysis of the fitness effects of mutations associated with resistance to protease inhibitors
    Henderson, GJ
    Parkin, N
    Swanstrom, R
    ANTIVIRAL THERAPY, 2005, 10 : S165 - S165
  • [43] The maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart
    Reyskens, Kathleen M. S. E.
    Essop, M. Faadiel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 3047 - 3049
  • [44] Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections
    Tan, Darrell
    Walmsley, Sharon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (01) : 13 - 28
  • [45] The Maladaptive Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir) on the Rat Heart
    Reyskens, Kathleen M. S. E.
    Fisher, Tarryn-Lee
    Schisler, Jonathan C.
    O'Connor, Wendi G.
    Rogers, Arlin B.
    Willis, Monte S.
    Planesse, Cynthia
    Rondeau, Philippe
    Bourdon, Emmanuel
    Essop, M. Faadiel
    PLOS ONE, 2013, 8 (09):
  • [46] The effect of the HIV protease Inhibitors indinavir and lopinavir/ritonavir on thrombolytic factors
    Lee, G. A.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L63 - L63
  • [47] Reduced susceptibility to lopinavir due to V32I/IA47A mutations in HIV-1 protease
    Stray, K
    Mulato, A
    MacArthur, H
    Leavitt, S
    Baer, C
    Liu, XH
    Callebaut, C
    He, GX
    McDermott, M
    Cihlar, T
    ANTIVIRAL RESEARCH, 2005, 65 (03) : A30 - A30
  • [48] Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
    Babrzadeh, Farbod
    Varghese, Vici
    Pacold, Mary
    Liu, Tommy F.
    Nyren, Pal
    Schiffer, Celia
    Fessel, W. Jeffrey
    Shafer, Robert W.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (02) : 414 - 418
  • [49] Genotypic and phenotypic cross-resistance patterns to lopinavir and amprenavir in protease inhibitor-experienced patients with HIV viremia
    Paulsen, D
    Liao, QM
    Fusco, G
    St Clair, M
    Shaefer, M
    Ross, L
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (14) : 1011 - 1019
  • [50] Selective vertical transmission of HIV-1 antiretroviral resistance mutations
    Colgrove, RC
    Pitt, J
    Chung, PH
    Welles, SL
    Japour, AJ
    AIDS, 1998, 12 (17) : 2281 - 2288
12345